<p>PharVision Advisers LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第四季度购买了 Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 免费报告）的新股份。该基金购买了 18,644 股公司股票，价值约为 245,000 美元。</p>
<ul>
<li>美敦力：稳定与创新的股息贵族</li>
</ul>
<p>其他一些大型投资者也对该公司的持股进行了调整。野村资产管理有限公司在第四季度将其在 Pediatrix Medical Group 的持股增加了 95.3%。野村资产管理有限公司现在拥有 2,500 股公司股票，价值 33,000 美元，此前在该期间又购买了 1,220 股。Parkside Financial Bank &amp; Trust 在第四季度将其在 Pediatrix Medical Group 的持股增加了 36.1%。Parkside Financial Bank &amp; Trust 现在拥有 3,919 股公司股票，价值 51,000 美元，此前在该期间又购买了 1,040 股。AlphaQuest LLC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 65.9%。AlphaQuest LLC 现在拥有 5,066 股公司股票，价值 66,000 美元，此前在该期间又购买了 2,012 股。Smartleaf Asset Management LLC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 750.9%。Smartleaf Asset Management LLC 现在拥有 6,901 股公司股票，价值 91,000 美元，此前在该期间又购买了 6,090 股。最后，Tower Research Capital LLC TRC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 218.0%。Tower Research Capital LLC TRC 现在拥有 7,445 股公司股票，价值 98,000 美元，此前在该期间又购买了 5,104 股。机构投资者和对冲基金持有公司 97.71% 的股票。</p>
<h2>分析师设定新目标价</h2>
<p>一些股票研究分析师最近对 MD 股票发布了报告。瑞银集团将 Pediatrix Medical Group 的目标价从 18.50 美元下调至 16.00 美元，并在 5 月 12 日的研究报告中对该公司给予了 “中性” 评级。Truist Financial 将 Pediatrix Medical Group 的目标价从 18.00 美元下调至 16.00 美元，并在 4 月 11 日的研究报告中对该公司给予了 “持有” 评级。最后，麦格理将 Pediatrix Medical Group 的目标价从 19.00 美元上调至 20.00 美元，并在 5 月 8 日的研究报告中给予了该公司 “跑赢大盘” 的评级。四位股票研究分析师对该股票给予了持有评级，三位给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 16.67 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
<p><strong>获取我们最新的 MD 股票分析</strong></p>
<h2>Pediatrix Medical Group 股票下跌 7.9%</h2>
<p>纽约证券交易所 MD 的股票在周五开盘价为 13.98 美元。该公司的市值为 12 亿美元，市盈率为 -11.65，市盈增长比率为 1.74，贝塔系数为 1.26。该公司的流动比率为 1.60，速动比率为 1.42，债务股本比率为 0.81。Pediatrix Medical Group, Inc. 的一年最低价为 6.62 美元，一年最高价为 17.67 美元。该公司的 50 日移动平均线为 13.78 美元，200 日移动平均线为 14.12 美元。</p>
<ul>
<li>美敦力的扩张势头增强——市场转变的时机？</li>
</ul>
<p>Pediatrix Medical Group（纽约证券交易所：MD - 获取免费报告）最近在 5 月 6 日发布了其财报。该公司报告季度每股收益（EPS）为 0.33 美元，超出市场共识预期的 0.25 美元，超出幅度为 0.08 美元。该公司季度收入为 4.5836 亿美元，而分析师预期为 4.5144 亿美元。Pediatrix Medical Group 的净利润率为 -4.92%，股本回报率为 15.47%。该公司季度收入同比下降 7.4%。去年同期，该公司每股收益为 0.20 美元。股票分析师预计 Pediatrix Medical Group, Inc. 今年将发布 1.38 美元的每股收益。</p>
<h2>关于 Pediatrix Medical Group</h2>
<p>（免费报告）</p>
<p>Pediatrix Medical Group, Inc. 及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，包括通过新生儿医学专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内对早产或有并发症的婴儿进行临床护理。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票而非 Pediatrix Medical Group</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>Joby 股票的波动：近期下跌的原因是什么？</li>
<li>三只小型股具有巨大的回报潜力</li>
<li>为什么嘉年华可能是终极非科技增长股</li>
<li>三只最佳金融科技股票以提升投资组合</li>
<li>超级微型计算机股票在沙特订单中开辟新路径</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
<p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐购买，以便在更广泛的市场注意到之前……而 Pediatrix Medical Group 并不在名单上。</p>
<p>虽然 Pediatrix Medical Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>PharVision Advisers LLC 在 Pediatrix Medical Group, Inc. (NYSE:MD) 中获得了新的股份，在第四季度购买了价值约 245,000 美元的 18,644 股。其他机构投资者也增加了在该公司的持仓。分析师对该股票设定了一致的 “持有” 评级，平均目标价为 16.67 美元。Pediatrix Medical Group 报告了上一季度每股收益为 0.33 美元，超出预期，但其收入同比下降了 7.4%</p>

<p>PharVision Advisers LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,644 shares of the company's stock, valued at approximately $245,000.</p>
<div class="lb-trans"><p>PharVision Advisers LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第四季度购买了 Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 免费报告）的新股份。该基金购买了 18,644 股公司股票，价值约为 245,000 美元。</p>
</div><ul>
<li>Medtronic: A Dividend Aristocrat With Stability and Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：稳定与创新的股息贵族</li>
</ul>
</div><p>A number of other large investors have also made changes to their positions in the company. Nomura Asset Management Co. Ltd. increased its stake in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the period. Parkside Financial Bank &amp; Trust boosted its holdings in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank &amp; Trust now owns 3,919 shares of the company's stock worth $51,000 after buying an additional 1,040 shares during the period. AlphaQuest LLC boosted its holdings in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after purchasing an additional 6,090 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投资者也对该公司的持股进行了调整。野村资产管理有限公司在第四季度将其在 Pediatrix Medical Group 的持股增加了 95.3%。野村资产管理有限公司现在拥有 2,500 股公司股票，价值 33,000 美元，此前在该期间又购买了 1,220 股。Parkside Financial Bank &amp; Trust 在第四季度将其在 Pediatrix Medical Group 的持股增加了 36.1%。Parkside Financial Bank &amp; Trust 现在拥有 3,919 股公司股票，价值 51,000 美元，此前在该期间又购买了 1,040 股。AlphaQuest LLC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 65.9%。AlphaQuest LLC 现在拥有 5,066 股公司股票，价值 66,000 美元，此前在该期间又购买了 2,012 股。Smartleaf Asset Management LLC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 750.9%。Smartleaf Asset Management LLC 现在拥有 6,901 股公司股票，价值 91,000 美元，此前在该期间又购买了 6,090 股。最后，Tower Research Capital LLC TRC 在第四季度将其在 Pediatrix Medical Group 的持股增加了 218.0%。Tower Research Capital LLC TRC 现在拥有 7,445 股公司股票，价值 98,000 美元，此前在该期间又购买了 5,104 股。机构投资者和对冲基金持有公司 97.71% 的股票。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of equities research analysts recently issued reports on MD shares. UBS Group dropped their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a &#34;neutral&#34; rating for the company in a research report on Monday, May 12th. Truist Financial lowered their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a &#34;hold&#34; rating for the company in a research report on Friday, April 11th. Finally, Macquarie raised their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average price target of $16.67.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对 MD 股票发布了报告。瑞银集团将 Pediatrix Medical Group 的目标价从 18.50 美元下调至 16.00 美元，并在 5 月 12 日的研究报告中对该公司给予了 “中性” 评级。Truist Financial 将 Pediatrix Medical Group 的目标价从 18.00 美元下调至 16.00 美元，并在 4 月 11 日的研究报告中对该公司给予了 “持有” 评级。最后，麦格理将 Pediatrix Medical Group 的目标价从 19.00 美元上调至 20.00 美元，并在 5 月 8 日的研究报告中给予了该公司 “跑赢大盘” 的评级。四位股票研究分析师对该股票给予了持有评级，三位给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 16.67 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
</div><p><strong>Get Our Latest Stock Analysis on MD</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 MD 股票分析</strong></p>
</div><h2>Pediatrix Medical Group Stock Down 7.9%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 7.9%</h2>
</div><p>Shares of NYSE MD opened at $13.98 on Friday. The firm has a market capitalization of $1.20 billion, a PE ratio of -11.65, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm's 50-day moving average is $13.78 and its 200-day moving average is $14.12.</p>
<div class="lb-trans"><p>纽约证券交易所 MD 的股票在周五开盘价为 13.98 美元。该公司的市值为 12 亿美元，市盈率为 -11.65，市盈增长比率为 1.74，贝塔系数为 1.26。该公司的流动比率为 1.60，速动比率为 1.42，债务股本比率为 0.81。Pediatrix Medical Group, Inc. 的一年最低价为 6.62 美元，一年最高价为 17.67 美元。该公司的 50 日移动平均线为 13.78 美元，200 日移动平均线为 14.12 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力的扩张势头增强——市场转变的时机？</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 EPS. Equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（纽约证券交易所：MD - 获取免费报告）最近在 5 月 6 日发布了其财报。该公司报告季度每股收益（EPS）为 0.33 美元，超出市场共识预期的 0.25 美元，超出幅度为 0.08 美元。该公司季度收入为 4.5836 亿美元，而分析师预期为 4.5144 亿美元。Pediatrix Medical Group 的净利润率为 -4.92%，股本回报率为 15.47%。该公司季度收入同比下降 7.4%。去年同期，该公司每股收益为 0.20 美元。股票分析师预计 Pediatrix Medical Group, Inc. 今年将发布 1.38 美元的每股收益。</p>
</div><h2>About Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>关于 Pediatrix Medical Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. 及其子公司在美国提供新生儿、母胎、儿科心脏病学及其他儿科专科护理服务。它提供新生儿护理服务，包括通过新生儿医学专科医生、新生儿护士执业者和其他儿科临床医生在医院特定病房内对早产或有并发症的婴儿进行临床护理。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>Turbulence for Joby Shares: What's Behind the Recent Dip?</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Why Carnival Could Be the Ultimate Non-Tech Growth Stock</li>
<li>3 Best Fintech Stocks for a Portfolio Boost</li>
<li>Super Micro Computer Stock Clears New Path Higher on Saudi Orders</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Pediatrix Medical Group</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>Joby 股票的波动：近期下跌的原因是什么？</li>
<li>三只小型股具有巨大的回报潜力</li>
<li>为什么嘉年华可能是终极非科技增长股</li>
<li>三只最佳金融科技股票以提升投资组合</li>
<li>超级微型计算机股票在沙特订单中开辟新路径</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Pediatrix Medical Group 吗？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐购买，以便在更广泛的市场注意到之前……而 Pediatrix Medical Group 并不在名单上。</p>
</div><p>While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Pediatrix Medical Group 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

PharVision Advisers LLC 在 Pediatrix Medical Group, Inc. (NYSE:MD) 中建立了 24.5 万美元的头寸